4-(2-carbazol-9-ylphenyl)-3-[3-ethenyl-2-[(Z)-prop-1-enyl]furo[2,3-a]carbazol-10-yl]benzonitrile
C44H29N3O — CID 129300009
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-(2-carbazol-9-ylphenyl)-3-[3-ethenyl-2-[(Z)-prop-1-enyl]furo[2,3-a]carbazol-10-yl]benzonitrile
4-(2-carbazol-9-ylphenyl)-3-[3-ethenyl-2-[(Z)-prop-1-enyl]furo[2,3-a]carbazol-10-yl]benzonitrile (PubChem CID 129300009) has the molecular formula C44H29N3O and a molecular weight of 615.74 g/mol. Its IUPAC name is 4-(2-carbazol-9-ylphenyl)-3-[3-ethenyl-2-[(Z)-prop-1-enyl]furo[2,3-a]carbazol-10-yl]benzonitrile.
Molecular Properties
| Compound Name | 4-(2-carbazol-9-ylphenyl)-3-[3-ethenyl-2-[(Z)-prop-1-enyl]furo[2,3-a]carbazol-10-yl]benzonitrile |
|---|---|
| PubChem CID | 129300009 |
| Molecular Formula | C44H29N3O |
| Molecular Weight | 615.74 g/mol |
| Exact Mass | 615.23 |
| IUPAC Name | 4-(2-carbazol-9-ylphenyl)-3-[3-ethenyl-2-[(Z)-prop-1-enyl]furo[2,3-a]carbazol-10-yl]benzonitrile |
| SMILES | C=Cc1c(/C=C\C)oc2c1ccc1c3ccccc3n(-c3cc(C#N)ccc3-c3ccccc3-n3c4ccccc4c4ccccc43)c12 |
| InChI | InChI=1S/C44H29N3O/c1-3-13-42-29(4-2)36-25-24-35-33-17-8-12-21-40(33)47(43(35)44(36)48-42)41-26-28(27-45)22-23-34(41)32-16-7-11-20-39(32)46-37-18-9-5-14-30(37)31-15-6-10-19-38(31)46/h3-26H,2H2,1H3/b13-3- |
| InChIKey | HVZCHQMIBUUZTD-DXNYSGJVSA-N |
| XLogP | 11.84 |
| TPSA | 46.79 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 48 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 615.74 |
| LogP ≤ 5 | 11.84 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 129300009 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.